CompletedNot Applicable

Prognostic Factors and Oncological Outcomes in Laparoscopic Liver Resection for CRLM

200 participantsStarted 2011-09-01

Plain-language summary

Laparoscopic liver resection (LLR) has gained acceptance as an effective treatment for colorectal liver metastases (CRLM) in selected patients, providing similar oncologic outcomes compared to open liver resection (OLR). A single-center retrospective analysis of a prospectively maintained database was performed. The primary aim of this study was to determine prognostic factors for the survival outcomes associated with LLR for CRLM.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients diagnosed with colorectal liver metastases * Patients who received laparoscopic liver resection for colorectal liver metastases * Patients who received the laparoscopic liver resection between September 2011 and mid-March 2020 Exclusion Criteria: * Patients with contraindication for laparoscopic liver resection * Refusal to participate in the study

What they're measuring

Survival outcomes

Timeframe: 9 years

Prognostic factors

Timeframe: 9 years

Trial details

NCT IDNCT05036265

SponsorGeneral Hospital Groeninge

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-03-15

View on ClinicalTrials.gov More Colorectal Cancer trials